Colleen Rock

Combining Pharmacotherapy of Iclepertin (BI 425809) With Computerized Cognitive Training in Patients With Schizophrenia: Baseline Data and Patient Demographics From an Ongoing Phase II Trial

Abstract: Introduction Iclepertin (BI 425809), a novel glycine transporter-1 inhibitor, had pro-cognitive effects in patients with schizophrenia in a Phase II trial; however, the effects ...

Colleen Rock ;

01/19/2023

Featured CME Course

Targeted Therapies for the Management of Chronic Lymphocytic Leukemia: Evaluating the Evidence to Optimize Patient Care and Outcomes

Upcoming Events

April 3 ⁠–⁠ April 4

April 5 ⁠–⁠ April 6

April 21 ⁠–⁠ April 24

April 29 ⁠–⁠ April 30

April 30 ⁠–⁠ May 4

May 1 ⁠–⁠ May 2

May 7 ⁠–⁠ May 9

May 8 ⁠–⁠ May 10

May 14 ⁠–⁠ May 16

May 19 ⁠–⁠ May 21

See Full Calendar

Colleen Rock

Featured CME Course

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products